logo

Quick Facts

Share

Micron Technology, Inc. (MU), which is hosting an Analyst and Investor Event later today, said it has raised its revenue and earnings per share outlook for its fiscal third quarter, which ends May 31, 2018. The company attributed the revised guidance to strong execution of its strategy and healthy industry...

Qualcomm Incorporated (QCOM) announced the commencement of a transaction to repurchase four series of its outstanding notes totaling $4 billion. The Cash Offers will expire on May 25, 2018. The Cash Offer Settlement Date will be promptly following the Cash Offer expiration date and is expected to be...

Hanmi Financial Corp. (HAFC), the holding company for Hanmi Bank, has agreed to acquire SWNB Bancorp, Inc., a privately-held bank holding company for Southwestern National Bank that is headquartered in Houston, Texas, the two companies said Monday. The aggregate consideration of the transaction is...

Petrobras (PBR) announced the commencement of offers by its wholly-owned subsidiary Petrobras Global Finance B.V. to purchase for cash PGF's notes for an aggregate purchase price, excluding accrued and unpaid interest, of up to $4.0 billion. The Tender Offers will expire on June 18, 2018. Notes tendered...

F5 Networks (FFIV) announced Francis "Frank" Pelzer has joined the company's leadership team as Executive Vice President and CFO. He will oversee F5's worldwide financial planning, analysis, accounting, reporting, and internal auditing procedures, as well as investor relations. Pelzer joins F5 from...

Wabtec Corp. (WAB) announced it a definitive agreement to combine with GE Transportation, a unit of General Electric Company (GE). GE will receive $2.9 billion in cash at closing and GE and its shareholders will receive a 50.1% ownership interest in the combined company, with Wabtec shareholders retaining...

Roper Technologies, Inc. (ROP) announced a definitive agreement to acquire PowerPlan in an all-cash transaction valued at $1.1 billion. PowerPlan is a provider of software and solutions for asset-centric companies, enabling its customers to optimize their financial performance and achieve regulatory...

Fifth Third Bancorp (FITB) and MB Financial, Inc. (MBFI) jointly announced a definitive merger agreement under which MB Financial will merge with Fifth Third Bancorp in a transaction valued at approximately $4.7 billion. Approximately 90 percent of the consideration will be in stock with the rest in...

Barclays PLC (BARC.L, BCS) announced that the Crown Court has dismissed all charges brought by the Serious Fraud Office, or SFO, against Barclays PLC and Barclays Bank PLC regarding matters which arose in the context of Barclays' capital raisings in 2008. The Group noted that the SFO is likely to seek...

GlaxoSmithKline PLC (GSK.L, GSK) reported that ViiV Healthcare, a specialist HIV company, majority owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, announced that the European Commission has granted marketing authorisation for Juluca for the treatment of human immunodeficiency...

IHS Markit (INFO) announced it has signed a definitive agreement to acquire Ipreo, a financial services solutions and data provider, for $1.855 billion from private equity funds managed by Blackstone and the Goldman Sachs Merchant Banking Division. The company said the Ipreo acquisition represents an...

Genentech, a member of the Roche Group (RHHBY), announced Monday that HEMLIBRA (emicizumab-kxwh) reduced treated bleeds by 96 percent compared to no prophylaxis in phase III HAVEN 3 study in hemophilia A without factor VIII inhibitors. The company announced full results from the Phase III HAVEN 3...

British drug major AstraZeneca (AZN.L, AZN) announced Monday that the US Food and Drug Administration or FDA has approved Lokelma (sodium zirconium cyclosilicate), formerly ZS-9, for the treatment of adults with hyperkalaemia. It is a serious condition characterised by elevated potassium levels in...

AstraZeneca PLC (AZN.L, AZN) announced the company has submitted a supplemental new drug application to Japan's Pharmaceuticals and Medical Devices Agency for the use of Forxiga (dapagliflozin), a selective sodium-glucose co-transporter 2 inhibitor, as an oral adjunct treatment to insulin in adults with...

Metso Corp. (MXCYY.PK), a Finland-based industrial company, announced Monday that its Board of Directors has appointed Pekka Vauramo President and CEO of Metso, effective as of November 2018 at the latest. CFO Eeva Sipilä will continue to serve as Metso's interim CEO until Vauramo begins in his new...

Follow RTT